From Single Product to Pharmacy Workflow AI Automation Infrastructure — How Listening to 100 Users Changed Everything

In 2016, Adebayo Alonge founded RxAll, initially developing an AI-powered spectrometer to combat counterfeit medications. Despite early struggles, a pivot during COVID-19 turned RxAll into a comprehensive pharmacy workflow platform, enhancing success and profitability. By addressing pharmacies' operational needs, adoption surged from 5% to 92%, solidifying their market presence.

The problem isn’t poverty; it’s a market flooded with free.

RxAll has evolved from a university sketch in 2010 to a billion AI sales engine across three continents by 2025. The journey emphasizes the importance of purpose, market integrity, and ethical monetization. Key principles include understanding the "why," avoiding free offerings, and pursuing global opportunities to impact African healthcare positively.